Regeneron Pharmaceuticals, Inc. (BVL:REGN)

Regeneron Pharmaceuticals Statistics

Total Valuation

BVL:REGN has a market cap or net worth of PEN 264.80 billion. The enterprise value is 210.49 billion.

Market Cap	264.80B
Enterprise Value	210.49B

Important Dates

The last earnings date was Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	Nov 20, 2025

Share Statistics

Current Share Class	100.78M
Shares Outstanding	n/a
Shares Change (YoY)	-4.39%
Shares Change (QoQ)	-1.29%
Owned by Insiders (%)	3.75%
Owned by Institutions (%)	87.79%
Float	98.56M

Valuation Ratios

The trailing PE ratio is 16.68 and the forward PE ratio is 16.64.

PE Ratio	16.68
Forward PE	16.64
PS Ratio	5.36
PB Ratio	2.47
P/TBV Ratio	2.58
P/FCF Ratio	18.09
P/OCF Ratio	15.06
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.16, with an EV/FCF ratio of 14.38.

EV / Earnings	13.26
EV / Sales	4.36
EV / EBITDA	14.16
EV / EBIT	16.24
EV / FCF	14.38

Financial Position

The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.09.

Current Ratio	4.06
Quick Ratio	3.19
Debt / Equity	0.09
Debt / EBITDA	0.62
Debt / FCF	0.64
Interest Coverage	90.81

Financial Efficiency

Return on equity (ROE) is 15.19% and return on invested capital (ROIC) is 7.27%.

Return on Equity (ROE)	15.19%
Return on Assets (ROA)	6.16%
Return on Invested Capital (ROIC)	7.27%
Return on Capital Employed (ROCE)	10.70%
Revenue Per Employee	3.25M
Profits Per Employee	1.04M
Employee Count	15,106
Asset Turnover	0.37
Inventory Turnover	2.46

Taxes

In the past 12 months, BVL:REGN has paid 1.97 billion in taxes.

Income Tax	1.97B
Effective Tax Rate	11.02%

Stock Price Statistics

The stock price has decreased by -29.35% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-29.35%
50-Day Moving Average	621.40
200-Day Moving Average	672.88
Relative Strength Index (RSI)	93.05
Average Volume (20 Days)	58

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.55

Income Statement

In the last 12 months, BVL:REGN had revenue of PEN 49.40 billion and earned 15.87 billion in profits. Earnings per share was 144.21.

Revenue	49.40B
Gross Profit	22.64B
Operating Income	13.25B
Pretax Income	17.84B
Net Income	15.87B
EBITDA	15.07B
EBIT	13.25B
Earnings Per Share (EPS)	144.21

Balance Sheet

The company has 29.27 billion in cash and 9.38 billion in debt, giving a net cash position of 55.56 billion.

Cash & Cash Equivalents	29.27B
Total Debt	9.38B
Net Cash	55.56B
Net Cash Per Share	n/a
Equity (Book Value)	107.33B
Book Value Per Share	1,044.10
Working Capital	47.00B

Cash Flow

In the last 12 months, operating cash flow was 17.58 billion and capital expenditures -2.94 billion, giving a free cash flow of 14.64 billion.

Operating Cash Flow	17.58B
Capital Expenditures	-2.94B
Free Cash Flow	14.64B
FCF Per Share	n/a

Margins

Gross margin is 45.83%, with operating and profit margins of 26.83% and 32.13%.

Gross Margin	45.83%
Operating Margin	26.83%
Pretax Margin	36.11%
Profit Margin	32.13%
EBITDA Margin	30.52%
EBIT Margin	26.83%
FCF Margin	29.63%

Dividends & Yields

This stock pays an annual dividend of 12.61, which amounts to a dividend yield of 1.68%.

Dividend Per Share	12.61
Dividend Yield	1.68%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	6.06%
Buyback Yield	4.39%
Shareholder Yield	6.07%
Earnings Yield	5.99%
FCF Yield	5.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVL:REGN has an Altman Z-Score of 6.89 and a Piotroski F-Score of 4.

Altman Z-Score	6.89
Piotroski F-Score	4